The economic burden of Clostridium difficile

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000–2012 M. Tvede,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-C. Lagier Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection S.B.

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

Varicella vaccination: a laboured take-off

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

S. M. Kotila, A. Virolainen, M. Snellman, S. Ibrahem, J. Jalava, O

Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis J.

Association of vancomycin serum concentrations with efficacy in patients with MRSA infections: a systematic review and meta-analysis T. Steinmetz, N.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Herpes zoster in non-hospitalized children

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Migrant health—a cause for concern?

Host factors are more important in predicting recurrent Clostridium difficile infection than ribotype and use of antibiotics Y.H. van Beurden, S. Nezami,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Virological tools to diagnose and monitor hepatitis C virus infection

A.E. Muller, U. Theuretzbacher, J.W. Mouton

E. Cambau, M. Drancourt Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

E. Bouza Clinical Microbiology and Infection

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

Comparing the economic and health benefits of different approaches to diagnosing Clostridium difficile infection Sarah M. Bartsch, Craig A. Umscheid,

Vector control: a cornerstone in the malaria elimination campaign

Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective J.A. Otter, P. Burgess,

E. Bouza, P. Muñoz, R. Alonso Clinical Microbiology and Infection

Training for the infectious diseases speciality in Norway

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

P. Seng, J.M. Rolain, D. Raoult, P. Brouqui

B. Gordts Clinical Microbiology and Infection

E. Charani, C. Tarrant, K. Moorthy, N. Sevdalis, L. Brennan, A. H

B. Y. Lee, Z. S. Wettstein, S. M. McGlone, R. R. Bailey, C. A

A multicentre, open-label, randomized comparative study of tigecycline versus ceftriaxone sodium plus metronidazole for the treatment of hospitalized.

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Metagenomics and probiotics

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

Laboratory diagnosis of Clostridium difficile disease

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

B. Y. Lee, A. Singh, M. Z. David, S. M. Bartsch, R. B. Slayton, S. S

Abstracts cont. Clinical Microbiology and Infection

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Vaccinations against respiratory tract infections at Hajj

R. U. Varier, E. Biltaji, K. J. Smith, M. S. Roberts, M. K. Jensen, J

S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K

Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013 U. Fedeli, E. Schievano,

Statin use and clinical outcomes among pneumonia patients

Microbiologic factors affecting Clostridium difficile recurrence

Nebulized hypertonic saline treatment in hospitalized children with moderate to severe viral bronchiolitis Z. Luo, Z. Fu, E. Liu, X. Xu, X. Fu, D. Peng,

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

C.P. Kelly Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Modelling during an emergency: the 2009 H1N1 influenza pandemic

The economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA B.Y. Lee, Y. Song, S.M. McGlone, R.R.

Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey A. Adler, Y.

J.L. Balcázar Clinical Microbiology and Infection

Typing of Clostridium difficile

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

The economic burden of Clostridium difficile S.M. McGlone, R.R. Bailey, S.M. Zimmer, M.J. Popovich, Y. Tian, P. Ufberg, R.R. Muder, B.Y. Lee Clinical Microbiology and Infection Volume 18, Issue 3, Pages 282-289 (March 2012) DOI: 10.1111/j.1469-0691.2011.03571.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 General decision model tree structure. *Give Tapered Vanomycin. ♦Use treatment strategy that was effective for prior episode. Treatment change: from metronidazole to vancomycin; no treatment change for vancomycin. Clinical Microbiology and Infection 2012 18, 282-289DOI: (10.1111/j.1469-0691.2011.03571.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Tornado diagrams showing the effect of each variable on the cost per CDI case from (a) the hospital perspective, (b) the third-party payer perspective, and (c) the societal perspective. Clinical Microbiology and Infection 2012 18, 282-289DOI: (10.1111/j.1469-0691.2011.03571.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions